SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted
暂无分享,去创建一个
L. Pagano | M. Rondoni | M. Mancini | P. Valent | S. Bruno | C. Papayannidis | S. Soverini | P. Tosi | M. Arock | M. Cavo | M. Bonifacio | M. Criscuolo | R. Zanotti | C. Sartor | S. De Santis | C. Monaldi | Samantha Bruno